Clinical Trial Update: Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both Medications [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing vildagliptin and liraglutide assessed patient treatment preference after receiving both drugs in adults with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Galvus (vildagliptin)
• Victoza (Liraglutide)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED